Large-scale testing (Phase 3)Active Not RecruitingNCT07214818What this trial is testingSGLT2 Inhibitors in Adult Primary Nephrotic SyndromeWho this might be right forNephrotic Syndrome Mansoura University 75
Early research (Phase 1)Looking for participantsNCT05521984What this trial is testingTargeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)Who this might be right forPediatric Brain TumorPediatric Solid Tumor Washington University School of Medicine 20
Post-approval studies (Phase 4)Study completedNCT03646292What this trial is testingAntidiabetic Drugs for Steatotic Liver DiseaseWho this might be right forMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more Yonsei University 51
Not applicableStudy completedNCT05344963What this trial is testingDeformation Imaging by Strain in Chronic Heart Failure Over Gliflozins: an Echocardiographic Register on Sodium-GLucose coTransporter-2 InhibitorsWho this might be right forSodium-GLucose coTransporter-2 InhibitorsHeart Failure With Reduced Ejection Fraction Matteo Cameli 503
Not applicableLooking for participantsNCT06932081What this trial is testingAdult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i RegistryWho this might be right forAdult Congenital Heart DiseaseCongenital Heart DiseaseSystemic Right Ventricle+5 more Leiden University Medical Center 400
Large-scale testing (Phase 3)UnknownNCT05601336What this trial is testingOf Sodium Glucose Cotransporter-2 Inhibitors on Metabolic, Hormonal and Clinical Parameters in PCOWho this might be right forPCO Beni-Suef University 200
Very early researchLooking for participantsNCT06609356What this trial is testingCardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 DiabetesWho this might be right forType 1 Diabetes MellitusGlucokinase-Maturity Onset Diabetes of the Young (GCK-MODY)MODY2 Diabetes+1 more Vanderbilt University Medical Center 27
Post-approval studies (Phase 4)WithdrawnNCT02768220What this trial is testingThe Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Advanced Glycation End ProductsWho this might be right forSGLT-2 InhibitorsAdvanced Glycation End ProductsDiabetes Northwell Health
Not applicableStudy completedNCT05990296What this trial is testingEvaluating Strategies to Improve Guideline Directed Medical Therapy: The GDMT Research, Education & Assist Trial for Heart Failure CareWho this might be right forHeart FailureHeart Failure With Reduced Ejection Fraction Geisinger Clinic 4,306
Not applicableLooking for participantsNCT06473844What this trial is testingEfficacy of SGLT2 Inhibitors in Adults With SepsisWho this might be right forSepsisInflammationSGLT2 Inhibitors+2 more Hospital Authority, Hong Kong 60
Not applicableStudy completedNCT04017221What this trial is testingSafety of Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors Among Patients with Type 2 DiabetesWho this might be right forDiabetes Mellitus, Type 2UrosepsisDiabetic Ketoacidosis+1 more Canadian Network for Observational Drug Effect Studies, CNODES 1,249,636
Not applicableStudy completedNCT06903754What this trial is testingISGLT2 in Patients Without DM With Acute MIWho this might be right forAcute Coronary SyndromesHeart Failure Mohammed VI University Hospital 450
Post-approval studies (Phase 4)Study completedNCT03030222What this trial is testingEmpagliflozin Impact on Hemodynamics in Patients With Heart FailureWho this might be right forHeart Failure Saint Luke's Health System 65
Not applicableStudy completedNCT07269197What this trial is testingAssociation of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 DiabetesWho this might be right forNon-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2 Josip Juraj Strossmayer University of Osijek 67
Large-scale testing (Phase 3)UnknownNCT05310916What this trial is testingEffect of SGLT2i on Diabetic Retinopathy in Type 2 Diabetes Mellitus PatientsWho this might be right forDiabetic Retinopathy Nidae Alaa 60
Not applicableStudy completedNCT03939624What this trial is testingSodium-glucose Cotransporter 2 (SGLT2) Inhibitors and Risk of Cardiovascular EventsWho this might be right forType2 DiabetesMyocardial InfarctionIschemic Stroke+3 more Canadian Network for Observational Drug Effect Studies, CNODES 419,734
Very early researchLooking for participantsNCT06430684What this trial is testingFeasibility Trial of Sodium-GLucose CoTransporter 2 INhibitors in Pediatric Chronic KIDney DiSeaseWho this might be right forChronic Kidney DiseasesPediatric Kidney Disease Ann & Robert H Lurie Children's Hospital of Chicago 40
Not applicableNot Yet RecruitingNCT06268977What this trial is testingUsing of SGLt2 Inhibitors in Patients With Type 2 DMWho this might be right forType 2 Diabetes Assiut University 400
Not applicableNot Yet RecruitingNCT06668753What this trial is testingEffect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic NephropathyWho this might be right forEffect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy Assiut University 114
Post-approval studies (Phase 4)Active Not RecruitingNCT05590143What this trial is testingProMoting Effective Renoprotection in Cardiac sURgery Patients by Inhibition of SGLT-2Who this might be right forAcute Kidney InjuryCardiac SurgerySodium-Glucose Transporter 2 Inhibitor Amsterdam UMC 784